Original articleThe virological and histological states of anti-hepatitis C virus—positive subjects with normal liver biochemical values
References (23)
- et al.
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
Lancet
(1992) - et al.
Persistent hepatitis C viremia without liver disease
Lancet
(1993) - et al.
Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease
Hepatology
(1993) - et al.
Antibody to hepatitis C virus in German blood donors
Lancet
(1989) - et al.
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
Genomics
(1989) - et al.
Hypervariable regions in the putative glycoprotein of hepatitis C virus
Biochem Biophys Res Commun
(1991) - et al.
Marked sequence diversity in the putative envelope proteins of hepatitis C viruses
Virus Res
(1992) - et al.
Changes in hepatitis C virus antigen in liver with antiviral therapy
Gastroenterology
(1993) - et al.
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
Science
(1989) - et al.
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
Science
(1989)
Antibody to hepatitis C virus and liver disease in volunteer blood donors
Ann Intern Med
Cited by (110)
Epidemiology of Hepatocellular Carcinoma
2015, Surgical Oncology Clinics of North AmericaCitation Excerpt :Chronic HCV infection is the leading cause of cirrhosis, and the most common indication for liver transplantation in North and South America, Europe, Australia, and Japan.38,40 Environmental factors such as age greater than 40 years at time of infection,41 degree of alcohol intake (greater than 40–50 g daily), male sex, obesity, presence of an increased alanine transaminase level42,43 and coinfection with HBV or HIV seem to have a greater impact than genotype or viral load in the progression to cirrhosis.39 Unlike other viral infections, antiviral treatment of HCV can eradicate the virus with sustained virologic response (SVR) and the absence of detectable HCV RNA after successful treatment.
Hepatitis C genotype 4 with normal transaminases: Correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients
2013, Clinics and Research in Hepatology and GastroenterologyCitation Excerpt :In our study when we compared patients with normal both aminotransferases (ALT and AST) with the other group of elevated both aminotransferases, we found that there is no statistically significant difference regarding age, sex, and BMI but when separating the aminotransferases, the significant statistical difference appears regarding sex in each AST and ALT separately that is proved by the available literature which suggests that PNALT are characterized by a higher prevalence of female sex only [10,24,25]. No major difference statistically between both groups in serum HCV-RNA titer (genotype 4) that exists in any other HCV genotypes worldwide, although European [21] and Japanese [26] studies show a trend towards a higher relative frequency of genotype (2a, 2b) in patients with normal transferases. This can be explained by the behaviour of chronic infection with HCV genotype 2, which often runs a course of mild necro-inflammation with persistently normal ALT for long periods of time intermingled with ALT flares and a rapid progression of fibrosis [27].
Hepatitis B Virus and Hepatitis C Virus: Molecular Biology and Diagnosis
2006, Perspectives in Medical VirologyCitation Excerpt :Around 25% of chronic HCV carriers may have normal aminotransferase levels (Alberti et al., 1992). These so-called healthy carriers do not differ from the chronic carries with abnormal aminotransferase levels in clinical or virological characteristics (Naito et al., 1994; Jamal et al., 1999), but the histological damage is milder and the progression of the liver lesion is slower than in chronic carriers with elevated aminotransferase levels (Shindo et al., 1995; Mathurin et al., 1998). Recently, a new form of HCV infection called “occult HCV infection” has been described in patients with abnormal liver function tests of unknown etiology (patients were anti-HCV and serum HCV-RNA negative, did not have markers of HBV infection and did not have clinical or biochemical evidences of autoimmunity, genetic or metabolic disorders, alcohol intake or drug toxicity).
Natural history of initially mild chronic hepatitis C
2004, Digestive and Liver DiseaseHepatitis C in a Los Ageles public hepatitis clinic: Demographic and biochemical differences associated with race-ethnicity
2004, Clinical Gastroenterology and HepatologyEpidemiology, mutational landscape and staging of hepatocellular carcinoma
2021, Chinese Clinical Oncology